Sections

Date of publication

No results were found for your search

Publicis Health to Acquire p-value Group

PDF

07/29/2025, New York

Publicis Health, the world’s most connected and data-powered health communications network, today announced its intent to acquire p-value Group, a premier full-service medical communications group serving top-tier life sciences clients. Founded in 2004 and headquartered in Cedar Knolls, New Jersey, p-value Group is widely recognized for its scientific rigor, deep therapeutic expertise, and a team of advanced-degree professionals. The agency is a trusted partner across the full product lifecycle, from early-stage development to commercialization.

This acquisition will uniquely position Publicis Health as the network to fuel the next generation of medical communications, which is the strategic bridge between scientific truth and commercial impact. As the life sciences industry faces rapid innovation, regulatory advancements, and increased competition, Publicis Health and p-value Group will accelerate the ability to connect data, technology, creative, therapeutic expertise and scientific integrity to shape strategy, inform decision-making, and drive outcomes-focused health results.

p-value Group will continue to be led by Founder and CEO Linda Corvari. The agency will sit within Publicis Health, strengthening the network’s existing global expertise, through Langland Medical and Razorfish Health while underscoring the commitment to advancing how science is communicated across the product lifecycle.

“p-value Group has built a reputation for unmatched scientific rigor and client partnership,” said Matt McNally, Global CEO of Publicis Health. “By joining forces, we’re amplifying the value we deliver to clients by bringing greater precision, speed, and strategic alignment across medical communications. This is about scaling what works, removing barriers, and delivering smarter solutions that drive measurable impact for our clients.”

“This is more than an acquisition, it’s a strategic alignment of vision and velocity,” said Linda Corvari, PharmD, Founder and CEO of p-value Group. “Publicis Health brings the scale, innovation, and purpose to take our work even further. Together, we’re redefining what’s possible in medical communications.”

The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close by the end of August 2025. 

ABOUT PUBLICIS GROUPE - THE POWER OF ONE

Publicis Groupe [Euronext Paris FR0000130577, CAC 40] is a global leader in communication. The Groupe is positioned at every step of the value chain, from consulting to execution, combining marketing transformation and digital business transformation. Publicis Groupe is a privileged partner in its clients’ transformation to enhance personalization at scale. The Groupe relies on ten expertise concentrated within four main activities: Communication, Media, Data and Technology. Through a unified and fluid organization, its clients have a facilitated access to all its expertise in every market. Present in over 100 countries, Publicis Groupe employs more than 108,000 professionals.

About Publicis Health

At Publicis Health, we believe keeping the world healthy is our most extraordinary social endeavor. Because one person’s wellbeing is the responsibility of the many. As part of Publicis Groupe and built on the world’s foremost intelligence platform, we create sharper, more memorable, and valuable brands for better outcomes. Powered by more than 8,000 healthcare communications, data, and medical specialists, our global agency collective is at the heart of international health communications. We Make Health Happen. For more information, visit us at www.publicishealth.com.

CONTACT US